CTV News Calgary: Resverlogix Announces COVID-19 Trial


Following new published evidence of apabetalone's benefit in COVID-19 (https://bit.ly/3sLCcBL​), made in collaboration with researchers at QIMR Berghofer Medical Research Institute, Resverlogix is announcing the initiation of human clinical trials


CTV Calgary News at 5 covered the announcement in this clip, which originally aired on March 11, 2021


SOURCE


#biotech #biotechnews #medicalresearch #clinicaltrials #CTV #research #pharma #covid19 #covid19news #biotechstocks #pennystocks #stockstowatch #smallcaps

Recent Posts

See All

Toronto | Montreal | Calgary | Vancouver

https://www.frontiermcg.com